MediWound Statistics
Total Valuation
MediWound has a market cap or net worth of $196.85 million. The enterprise value is $174.96 million.
Important Dates
The next estimated earnings date is Tuesday, November 19, 2024, before market open.
| Earnings Date | Nov 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MediWound has 10.79 million shares outstanding. The number of shares has increased by 28.90% in one year.
| Current Share Class | 10.79M |
| Shares Outstanding | 10.79M |
| Shares Change (YoY) | +28.90% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 1.93% |
| Owned by Institutions (%) | 28.65% |
| Float | 6.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.41 |
| Forward PS | 7.00 |
| PB Ratio | 9.53 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.65 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.35 |
Financial Efficiency
Return on equity (ROE) is -75.66% and return on invested capital (ROIC) is -32.07%.
| Return on Equity (ROE) | -75.66% |
| Return on Assets (ROA) | -15.77% |
| Return on Capital (ROIC) | -32.07% |
| Revenue Per Employee | $201,410 |
| Profits Per Employee | -$199,730 |
| Employee Count | 100 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 5.53 |
Taxes
In the past 12 months, MediWound has paid $190,000 in taxes.
| Income Tax | 190,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +123.11% in the last 52 weeks. The beta is 0.84, so MediWound's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +123.11% |
| 50-Day Moving Average | 17.48 |
| 200-Day Moving Average | 16.59 |
| Relative Strength Index (RSI) | 58.96 |
| Average Volume (20 Days) | 32,574 |
Short Selling Information
| Short Interest | 594,343 |
| Short Previous Month | 579,421 |
| Short % of Shares Out | 6.44% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 15.59 |
Income Statement
In the last 12 months, MediWound had revenue of $20.14 million and -$19.97 million in losses. Loss per share was -$2.16.
| Revenue | 20.14M |
| Gross Profit | 2.67M |
| Operating Income | -15.35M |
| Pretax Income | -12.55M |
| Net Income | -19.97M |
| EBITDA | -14.50M |
| EBIT | -15.35M |
| Loss Per Share | -$2.16 |
Full Income StatementBalance Sheet
The company has $29.22 million in cash and $6.36 million in debt, giving a net cash position of $22.86 million or $2.12 per share.
| Cash & Cash Equivalents | 29.22M |
| Total Debt | 6.36M |
| Net Cash | 22.86M |
| Net Cash Per Share | $2.12 |
| Equity (Book Value) | 17.87M |
| Book Value Per Share | 1.92 |
| Working Capital | 14.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.10 million and capital expenditures -$8.17 million, giving a free cash flow of -$22.27 million.
| Operating Cash Flow | -14.10M |
| Capital Expenditures | -8.17M |
| Free Cash Flow | -22.27M |
| FCF Per Share | -$2.06 |
Full Cash Flow StatementMargins
Gross margin is 13.25%, with operating and profit margins of -76.20% and -99.17%.
| Gross Margin | 13.25% |
| Operating Margin | -76.20% |
| Pretax Margin | -98.22% |
| Profit Margin | -99.17% |
| EBITDA Margin | -72.01% |
| EBIT Margin | -76.20% |
| FCF Margin | -110.54% |
Dividends & Yields
MediWound does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.90% |
| Shareholder Yield | -28.90% |
| Earnings Yield | -10.10% |
| FCF Yield | -11.26% |
Analyst Forecast
The average price target for MediWound is $28.00, which is 53.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.00 |
| Price Target Difference | 53.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 46.44% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 20, 2022. It was a reverse split with a ratio of 0.1428571:1.
| Last Split Date | Dec 20, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1428571:1 |
Scores
MediWound has an Altman Z-Score of -3.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.18 |
| Piotroski F-Score | 1 |